Aristo Bio-Tech and Lifescience Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

6.81

6.81

6.81

5.00

5.00

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

30.52

26.80

23.35

9.85

8.39

Loan funds

Secured loans

21.85

20.88

22.49

25.48

22.25

Unsecured loans

-

-

-

-

-

Total

59.19

54.48

52.65

40.33

35.63

Uses of funds

Fixed assets

Gross block

34.76

30.19

22.73

19.94

16.88

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

10.81

8.51

7.11

5.58

4.56

Net block

23.95

21.68

15.62

14.36

12.31

Capital work-in-progress

-

-

1.10

0.10

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

116.67

105.61

83.11

62.54

69.10

Less : current liabilities & provisions

81.44

72.80

47.18

36.67

45.79

Total net current assets

35.23

32.80

35.93

25.87

23.31

Miscellaneous expenses not written

-

-

-

-

-

Total

59.19

54.48

52.65

40.33

35.63

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.18

0.48

0.72

0.65

0.06

Number of equity sharesoutstanding (Lacs)

68.08

68.08

68.08

49.95

49.95